Member Info for Brainer

Evalu8, for your information: before close sell price was 4.20p and buy price 5.25p with nt, so good luck buying Monday!

Mr evalu8 now actually did some research and regretting not buying before close on Friday, therefore all this research to ensure he can buy Monday as cheap as possible but I don’t think you get in below 6p, keep trying, your devastation is attracting more people and due to the number of post you made, we are on top of chat list which is making more people research this company.

Most followed company okyo! https://mobile.twitter.com/VOXmarkets/status/1020318717358600192

Share price always goes mental on rumours and anticipation of potential rather then fact, so considering peoples interest and as some are researching now, I think we are actually heading toward 20p first before anything else. The licence worth loads!

Evalue, you can’t do math and now you can fooking read? It clearly states on that holding RNS, interest increased from 16% to 30%, they started buying soon as the talk of transforming to pharmaceutical company started, you are providing a lot of wrong information, go to the link and read:’

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=WAFM&ArticleCode=ru1wvdtl&ArticleHeadline=Holdings_in_Company

Evalue, I think you need to relax, you are stressing too much, you need some rest as you worked hard here whole day.
You said sorry after I pointed out you are wrong about shareholders info, you need to say sorry about Panetta Partners buying from market 30% as I have shown you proof.

...In 2017, source http://www.lse.co.uk/share-regulatory-news.asp?shareprice=WAFM&ArticleCode=ru1wvdtl&ArticleHeadline=Holdings_in_Company

Now do me a favour eValue, buy first thing Monday morning at whatever price you can get, that will keep you stress free as you seem to post more then any1 else without holding and going on about same thing after clarifying.

You just have a bad argument there, let’s agree with you and exclude the 22% of Beaufort Nominees.
A calculator will help you if you can’t use brain lol:

Panetta Partners 47.95% + regent marchentile 6.24% + James Mellon 6.09%+ rosey mining 6.85% = 67.13%
So, 100 - 67.13 = 32.87

That clearly means, they meant to write 32% is in public hand and approximately 68% isn’t.

However, if the 22% from Beaufort nominees not available to trade then available to trade share is 10.45% only

So you are saying 32% not in public hand, means 68% in public hand when Panetta Partners alone holds 251 millions out of 523 millions, forget about the rest of the institutions holders, it’s a typo error their, do your math mate, Panetta Partners bought 30% (116 million) from market at much higher price when Okyo was wafm.
I am observing they are buying more from market now

When sp started rising on Thursday, 5 transaction took place under 4p including mine with nt exactly at 4p, out of 5 cheapest was at 3.50p, so anyone dreaming of 2p can keep on dreaming, it has 99.99% chance of doing 20p then 2p. Good luck buying Monday!

Calculate each institutions holding, 32% old news, they all increased to total 89.55%, that’s why it’s been rising on no visible trades. It was 32% when Panetta Partners had 116 million shares and now they hold more then 250 million shares.

Holdings of Significant Shareholders
As of 22 May 2018 OKYO Pharma is aware of the following persons who hold, directly or indirectly, voting rights representing 5% or more of the issued share capital of OKYO Pharma to which voting rights are attached:
Name
Number of Shares
Percentage of issued share capital
Panetta Partners Limited
251,087,103
47.95%

Beaufort Nominees Limited
117,466,234
22.43%

Rosy Mining Limited
35,889,079
6.85%

Regent Mercantile Holdings Limited
32,672,906
6.24%

James Mellon
31,912,948
6.09%

If anyone can buy below 6p on Monday! Before people bought without research and panic sold, now some are actually researching, only 10.45% free float, 89.55% held by multiple institutions, licenced to develop drags, main market listing! More chance of 20p then 2p, welcome to the show on Monday!

There is no clear cut info, you need to read all RNS from last one year, took me hours of study

You need to read all last one year RNS from their website to understand this, most of the RNS are not shown here on lse bb

OKYO needed to raise £6 millions on re-admission to main market to avoid suspension. OKYO had 388 million shares before re-admission to main market from AIM, Panetta Partners Limited had 30% interest in OKYO when it was WAFM, Panetta Partners Limited made an aquisation for farther 19% and other institutions made acquisition which raised £6 millions that was required for re-admission, that’s how current issued share is 523 millions, all institutions increased total interest from 32% to 89.55%!
So £6 millions raised plus they had over £2 millions cash, total around £8 millions.
That needs to be priced in and if it does we could see 20p in days!

They institutions has increased their holdings from 32% to 89.55% on reverse takeover, that’s not priced in yet, also they raised £6 millions cash on admission to main market, cash around £8 millions now, that’s more then enough to develop the drag, besides they are supported by all the major institution holders.
None of them priced in, that’s why market making correction on price, yesterday they triggered stop losses which you shouldn’t use in stock like this! Dyor

Calculate each institutions holding, 32% old news, they all increased to 89.55%, that’s why it’s been rising on no visible trades.

Holdings of Significant Shareholders
As of 22 May 2018 OKYO Pharma is aware of the following persons who hold, directly or indirectly, voting rights representing 5% or more of the issued share capital of OKYO Pharma to which voting rights are attached:
Name
Number of Shares
Percentage of issued share capital
Panetta Partners Limited
251,087,103
47.95%

Beaufort Nominees Limited
117,466,234
22.43%

Rosy Mining Limited
35,889,079
6.85%

Regent Mercantile Holdings Limited
32,672,906
6.24%

James Mellon
31,912,948
6.09%

Look I don’t tell anyone to buy, yesterday first I bought at 4p with nt for £5k then sold at 6p in 20 minutes, yesterday I bought without much research as I saw it’s looking like going to pay and it did.

However did some research last night and today and decided to buy back at lower price, and bought twice, so current average less then 3.50p.
I don’t know what’s the market going to do with price, but if you consider the institutions were paying up to 55p a share when it was WAFM, they didn’t sell any instead bought more, now the company changed to a pharmaceutical company from mineral company with the support of shareholders as per RNS(not shown here, look on website)

The institutions currently hold 89.55% of issued share capital, and they will do something to make money or get their money back, therefore Name Charged, entry to Main market, in talk for a pharmaceutical deal.

I don’t know what’s gonna happen or what they are up to, but for sure something will happen. Today board didn’t disagree with the 200% rise, that’s a good news itself.

I have seen and pretty sure you guys witnessed the same over the years, some company just kept rising and did 10 to 20 bagger without even any news over few days! with this one news expected, how it’s rising with small volume, this one could be one of them.
However I don’t predict any price, I just think it will be a fun ride which I decided to be part of!

So, 10.45% available to trade, that’s 50 millions share only! on top of that someone buying more for last few days!

Source: http://okyopharma.com/content/investor-centre/share-information

Companies with £100 millions market capital can’t have access to main market, how do you think OKYO got access to main market? Something in the making! They are after a big pharmaceutical acquisition and fund likely to come from all those institutional holders:

Scully, autopilot can read what’s happening here more then you lol, strong buy indeed